Upregulated enhancer of rudimentary homolog promotes epithelial‑mesenchymal transition and cancer cell migration in lung adenocarcinoma

Lung adenocarcinoma (LUAD) is one of the deadliest cancers regarding both mortality rate and number of deaths and warrants greater effort in the development of potential therapeutic targets. The enhancer of rudimentary homolog ( ) has been implicated in the promotion and progression of certain types...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Molecular medicine reports 2024-01, Vol.29 (1), Article 9
Hauptverfasser:	Tsai, Ying-Ming, Wu, Kuan-Li, Huang, Yung-Chi, Wu, Yu-Yuan, Chang, Chao-Yuan, Chang, Yung-Yun, Chiang, Hung-Hsing, Liu, Lian-Xiu, Hung, Jen-Yu
Format:	Artikel
Sprache:	eng
Schlagworte:	Adenocarcinoma Adenocarcinoma of Lung - pathology Biotechnology industry Cell cycle Cell Line, Tumor Cell migration Cell Movement - genetics Cell Proliferation - genetics Clinical outcomes Consortia Epithelial-Mesenchymal Transition - genetics Gene expression Gene Expression Regulation, Neoplastic Genomes Humans Lung cancer Lung Neoplasms - pathology Medical prognosis Medical screening Ovarian cancer Penicillin Protein expression Proteins Proteomics Survival analysis Therapeutic targets Thoracic surgery Transcriptomics Tumor Microenvironment Tumors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!